Physician profile
Christopher Alan Snyder
NPI 1912973801
$24,245.39
in general payments reported to CMS, 2019-2025
43 companies · $5,590 in 2025
The $5,590 reported for 2025 was more than what 90% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,207 · 2020: $1,784 · 2021: $2,308 · 2022: $3,242 · 2023: $3,117 · 2024: $4,998 · 2025: $5,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,329.77 |
| Education | $375.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,367.92 | 2019-2025 | Skyrizi, Rinvoq, Humira |
| Janssen Biotech, INC. | $2,591.76 | 2019-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $1,822.92 | 2019-2025 | Ilumya, Winlevi |
| Genzyme Corporation | $1,546.45 | 2019-2025 | |
| Ucb, INC. | $1,477.03 | 2019-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $1,465.82 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Leo Pharma INC. | $1,417.74 | 2019-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $1,214.32 | 2019-2025 | Dupixent, Libtayo |
| Pfizer INC. | $1,177.49 | 2019-2025 | |
| Galderma Laboratories, L.P. | $954.29 | 2019-2025 | Nemluvio, Aklief, Epsolay |
| Amgen INC. | $943.44 | 2019-2025 | Otezla, Otezla |
| Incyte Corporation | $743.34 | 2021-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $734.70 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $694.35 | 2022-2025 | Sotyktu |
| Biofrontera INC. | $560.71 | 2019-2024 | Xepi, Bf-Rhodoled, Ameluz |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.